Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Julphar
Express Scripts
Cipla
UBS
Johnson and Johnson
Cantor Fitzgerald
Farmers Insurance
Healthtrust

Generated: December 12, 2018

DrugPatentWatch Database Preview

Antares Pharma Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ANTARES PHARMA INC, and when can generic versions of ANTARES PHARMA INC drugs launch?

ANTARES PHARMA INC has three approved drugs.

There are sixteen US patents protecting ANTARES PHARMA INC drugs.

There are fifty-five patent family members on ANTARES PHARMA INC drugs in twelve countries.

Summary for Antares Pharma Inc
International Patents:55
US Patents:16
Tradenames:4
Ingredients:3
NDAs:3
Patent Litigation for Antares Pharma Inc: See patent lawsuits for Antares Pharma Inc

Drugs and US Patents for Antares Pharma Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Antares Pharma Inc OTREXUP methotrexate SOLUTION;SUBCUTANEOUS 204824-007 Mar 24, 2016 RX Yes Yes 9,421,333 ➤ Sign Up Y ➤ Sign Up
Antares Pharma Inc OTREXUP methotrexate SOLUTION;SUBCUTANEOUS 204824-004 Oct 11, 2013 RX Yes Yes 7,776,015 ➤ Sign Up Y ➤ Sign Up
Antares Pharma Inc OTREXUP methotrexate SOLUTION;SUBCUTANEOUS 204824-005 Nov 7, 2014 DISCN Yes No 8,945,063 ➤ Sign Up Y ➤ Sign Up
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-001 Sep 28, 2018 RX Yes Yes 9,533,102 ➤ Sign Up Y ➤ Sign Up
Antares Pharma Inc XYOSTED (AUTOINJECTOR) testosterone enanthate SOLUTION;SUBCUTANEOUS 209863-002 Sep 28, 2018 RX Yes Yes 8,021,335 ➤ Sign Up Y ➤ Sign Up
Antares Pharma Inc OTREXUP methotrexate SOLUTION;SUBCUTANEOUS 204824-001 Oct 11, 2013 RX Yes Yes 6,746,429 ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Antares Pharma Inc Drugs

Country Document Number Estimated Expiration
Germany 69908140 ➤ Sign Up
South Korea 20120028294 ➤ Sign Up
China 101132820 ➤ Sign Up
World Intellectual Property Organization (WIPO) 2013012745 ➤ Sign Up
Austria 281195 ➤ Sign Up
World Intellectual Property Organization (WIPO) 2013169800 ➤ Sign Up
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Teva
Deloitte
Healthtrust
Covington
Merck
Fuji
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.